Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease

Human Molecular Genetics

Volumn 19, Issue 17, 2010, Pages 3468-3476

  McGovern, Dermot P B ^a   Jones, Michelle R ^a   Taylor, Kent D ^a   Marciante, Kristin ^b   Yan, Xiaofei ^a   Dubinsky, Marla ^a   Ippoliti, Andy ^a   Vasiliauskas, Eric ^a   Berel, Dror ^a   Derkowski, Carrie ^a   Dutridge, Deb ^a   Fleshner, Phil ^a   Shih, David Q ^a   Melmed, Gil ^a   Mengesha, Emebet ^a   King, Lily ^a   Pressman, Sheila ^a   Haritunians, Talin ^a   Guo, Xiuqing ^a   Targan, Stephan R ^a   Rotter, Jerome I ^a   more..

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP A ANTIGEN; BLOOD GROUP B ANTIGEN; FUCOSYLTRANSFERASE; FUCOSYLTRANSFERASE 2; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADULT; ANTIGEN EXPRESSION; ARPC1A GENE; ARTICLE; ASHL GENE; CADM1 GENE; CAUCASIAN; CHILD; CONTROLLED STUDY; CROHN DISEASE; CYTOLOGY; DENDRITIC CELL; EPITHELIUM; EXOC2 GENE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; IGSF4 GENE; INNATE IMMUNITY; MACROPHAGE; MAJOR CLINICAL STUDY; MAP3K7IP1 GENE; MMD2 GENE; MULTIDIMENSIONAL SCALING; PATHOGENESIS; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; TIGHT JUNCTION;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CROHN DISEASE; FEMALE; FUCOSYLTRANSFERASES; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 77955398591     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq248     Document Type: Article

References (76)

1. Kim, S.C., Tonkonogy, S.L., Albright, C.A., Tsang, J., Balish, E.J., Braun, J., Huycke, M.M. and Sartor, R.B. (2005) Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology, 128, 891-906.
2. Rath, H.C., Herfarth, H.H., Ikeda, J.S., Grenther, W.B., Hamm, T.E. Jr, Balish, E., Taurog, J.D., Hammer, R.E., Wilson, K.H. and Sartor, R.B. (1996) Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J. Clin. Invest., 98, 945-953.
3. Rath, H.C., Wilson, K.H. and Sartor, R.B. (1999) Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli. Infect. Immun., 67, 2969-2974.
4. Rath, H.C., Ikeda, J.S., Linde, H.J., Scholmerich, J., Wilson, K.H. and Sartor, R.B. (1999) Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats. Gastroenterology, 116, 310-319.
5. Gionchetti, P., Rizzello, F., Venturi, A., Brigidi, P., Matteuzzi, D., Bazzocchi, G., Poggioli, G., Miglioli, M. and Campieri, M. (2000) Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology, 119, 305-309.
6. Rutgeerts, P., Hiele, M., Geboes, K., Peeters, M., Penninckx, F., Aerts, R. and Kerremans, R. (1995) Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology, 108, 1617-1621.
7. Landers, C.J., Cohavy, O., Misra, R., Yang, H., Lin, Y.C., Braun, J. and Targan, S.R. (2002) Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto-and microbial antigens. Gastroenterology, 123, 689-699.
8. Duerr, R.H., Taylor, K.D., Brant, S.R., Rioux, J.D., Silverberg, M.S., Daly, M.J., Steinhart, A.H., Abraham, C., Regueiro, M., Griffiths, A. et al. (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science, 314, 1461-1463.
9. Hampe, J., Franke, A., Rosenstiel, P., Till, A., Teuber, M., Huse, K., Albrecht, M., Mayr, G., De La Vega, F.M., Briggs, J. et al. (2007) A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet., 39, 207-211.
10. Rioux, J.D., Xavier, R.J., Taylor, K.D., Silverberg, M.S., Goyette, P., Huett, A., Green, T., Kuballa, P., Barmada, M.M., Datta, L.W. et al. (2007) Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet., 39, 596-604.
11. Yamazaki, K., McGovern, D., Ragoussis, J., Paolucci, M., Butler, H., Jewell, D., Cardon, L., Takazoe, M., Tanaka, T., Ichimori, T. et al. (2005) Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum. Mol. Genet., 14, 3499-3506.
12. Hugot, J.P., Chamaillard, M., Zouali, H., Lesage, S., Cezard, J.P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C.A., Gassull, M. et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature, 411, 599-603.
13. Ogura, Y., Bonen, D.K., Inohara, N., Nicolae, D.L., Chen, F.F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R.H. et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature, 411, 603-606.
14. Libioulle, C., Louis, E., Hansoul, S., Sandor, C., Farnir, F., Franchimont, D., Vermeire, S., Dewit, O., de Vos, M., Dixon, A. et al. (2007) Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet., 3, e58.
15. Barrett, J.C., Hansoul, S., Nicolae, D.L., Cho, J.H., Duerr, R.H., Rioux, J.D., Brant, S.R., Silverberg, M.S., Taylor, K.D., Barmada, M.M. et al. (2008) Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet., 40, 955-962.
16. De Jager, P.L., Franchimont, D., Waliszewska, A., Bitton, A., Cohen, A., Langelier, D., Belaiche, J., Vermeire, S., Farwell, L., Goris, A. et al. (2007) The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun., 8, 387-397.
17. Saruta, M., Targan, S.R., Mei, L., Ippoliti, A.F., Taylor, K.D. and Rotter, J.I. (2009) High-frequency haplotypes in the X chromosome locus TLR8 are associated with both CD and UC in females. Inflamm. Bowel. Dis., 15, 321-327.
18. Parkes, M., Barrett, J.C., Prescott, N.J., Tremelling, M., Anderson, C.A., Fisher, S.A., Roberts, R.G., Nimmo, E.R., Cummings, F.R., Soars, D. et al. (2007) Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat. Genet., 39, 830-832.
19. Mow, W.S., Vasiliauskas, E.A., Lin, Y.C., Fleshner, P.R., Papadakis, K.A., Taylor, K.D., Landers, C.J., Abreu-Martin, M.T., Rotter, J.I., Yang, H. et al. (2004) Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology, 126, 414-424.
20. Ikehara, Y., Nishihara, S., Yasutomi, H., Kitamura, T., Matsuo, K., Shimizu, N., Inada, K., Kodera, Y., Yamamura, Y., Narimatsu, H. et al. (2001) Polymorphisms of two fucosyltransferase genes (Lewis and Secretor genes) involving type I Lewis antigens are associated with the presence of anti-Helicobacter pylori IgG antibody. Cancer Epidemiol. Biomarkers Prev., 10, 971-977.
21. Marionneau, S., Airaud, F., Bovin, N.V., Le Pendu, J. and Ruvoen-Clouet, N. (2005) Influence of the combined ABO, FUT2 and FUT3 polymorphism on susceptibility to Norwalk virus attachment. J. Infect. Dis., 192, 1071-1077.
22. Thorven, M., Grahn, A., Hedlund, K.O., Johansson, H., Wahlfrid, C., Larson, G. and Svensson, L. (2005) A homozygous nonsense mutation (428G->A) in the human secretor (FUT2) gene provides resistance to symptomatic norovirus (GGII) infections. J. Virol., 79, 15351-15355.
23. Carlsson, B., Kindberg, E., Buesa, J., Rydell, G.E., Lidon, M.F., Montava, R., Abu Mallouh, R., Grahn, A., Rodriguez-Diaz, J., Bellido, J. et al. (2009) The G428A nonsense mutation in FUT2 provides strong but not absolute protection against symptomatic GII.4 Norovirus infection. PLoS One, 4, e5593.
24. Kindberg, E., Hejdeman, B., Bratt, G., Wahren, B., Lindblom, B., Hinkula, J. and Svensson, L. (2006) A nonsense mutation (428G-> A) in the fucosyltransferase FUT2 gene affects the progression of HIV-1 infection. AIDS, 20, 685-689.
25. Hazra, A., Kraft, P., Selhub, J., Giovannucci, E.L., Thomas, G., Hoover, R.N., Chanock, S.J. and Hunter, D.J. (2008) Common variants of FUT2 are associated with plasma vitamin B12 levels. Nat. Genet., 40, 1160-1162.
26. Kelly, R.J., Rouquier, S., Giorgi, D., Lennon, G.G. and Lowe, J.B. (1995) Sequence and expression of a candidate for the human Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J. Biol. Chem., 270, 4640-4649.
27. Evans, D.A., Horwich, L., McConnell, R.B. and Bullen, M.F. (1968) Influence of the ABO blood groups and secretor status on bleeding and on perforation of duodenal ulcer. Gut, 9, 319-322.
28. Thom, S.M., Blackwell, C.C., MacCallum, C.J., Weir, D.M., Brettle, R.P., Kinane, D.F. and Wray, D. (1989) Non-secretion of blood group antigens and susceptibility to infection by Candida species. FEMS Microbiol. Immunol., 1, 401-405.
29. Aly, F.Z., Blackwell, C.C., MacKenzie, D.A., Weir, D.M., Elton, R.A., Cumming, C.G., Sofaer, J.A. and Clarke, B.F. (1991) Chronic atrophic oral candidiasis among patients with diabetes mellitus-role of secretor status. Epidemiol. Infect., 106, 355-363.
30. Haverkorn, M.J. and Goslings, W.R. (1969) Streptococci, ABO blood groups, and secretor status. Am. J. Hum. Genet., 21, 360-375.
31. Kinane, D.F., Blackwell, C.C., Brettle, R.P., Weir, D.M., Winstanley, F.P. and Elton, R.A. (1982) ABO blood group, secretor state, and susceptibility to recurrent urinary tract infection in women. Br. Med. J. (Clin Res Ed), 285,7-9.
32. Chaudhuri, A. and DasAdhikary, C.R. (1978) Possible role of blood-group secretory substances in the aetiology of cholera. Trans. R. Soc. Trop. Med. Hyg., 72, 664-665.
33. Blackwell, C.C., Jonsdottir, K., Hanson, M., Todd, W.T., Chaudhuri, A.K., Mathew, B., Brettle, R.P. and Weir, D.M. (1986) Non-secretion of ABO antigens predisposing to infection by Neisseria meningitidis and Streptococcus pneumoniae. Lancet, 2, 284-285.
34. Blackwell, C.C., Jonsdottir, K., Hanson, M.F. and Weir, D.M. (1986) Non-secretion of ABO blood group antigens predisposing to infection by Haemophilus influenzae. Lancet, 2, 687.
35. Zhernakova, A., Festen, E.M., Franke, L., Trynka, G., van Diemen, C.C., Monsuur, A.J., Bevova, M., Nijmeijer, R.M., van 't Slot, R., Heijmans, R. et al. (2008) Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP. Am. J. Hum. Genet., 82, 1202-1210.
36. McGovern, D.P., Gardet, A., Torkvist, L., Goyette, P., Essers, J., Taylor, K.D., Neale, B.M., Ong, R.T., Lagace, C., Li, C. et al. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat. Genet., 42, 332-337.
37. Ishikawa, H., Ma, Z. and Barber, G.N. (2009) STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature, 461, 788-792.
38. Laitinen, T., Polvi, A., Rydman, P., Vendelin, J., Pulkkinen, V., Salmikangas, P., Makela, S., Rehn, M., Pirskanen, A., Rautanen, A. et al. (2004) Characterization of a common susceptibility locus for asthma-related traits. Science, 304, 300-304.
39. Sleiman, P.M., Flory, J., Imielinski, M., Bradfield, J.P., Annaiah, K., Willis-Owen, S.A., Wang, K., Rafaels, N.M., Michel, S., Bonnelykke, K. et al. Variants of DENND1B associated with asthma in children. N. Engl. J. Med., 362, 36-44.
40. Dixon, A.L., Liang, L., Moffatt, M.F., Chen, W., Heath, S., Wong, K.C., Taylor, J., Burnett, E., Gut, I., Farrall, M. et al. (2007) A genome-wide association study of global gene expression. Nat. Genet., 39, 1202-1207.
41. van Heel, D.A., Fisher, S.A., Kirby, A., Daly, M.J., Rioux, J.D. and Lewis, C.M. (2004) Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum. Mol. Genet., 13, 763-770.
42. Villette, S., Kyle, J.A., Brown, K.M., Pickard, K., Milne, J.S., Nicol, F., Arthur, J.R. and Hesketh, J.E. (2002) A novel single nucleotide polymorphism in the 3' untranslated region of human glutathione peroxidase 4 influences lipoxygenase metabolism. Blood Cells Mol. Dis., 29, 174-178.
43. Batra, J., Rajpoot, R., Ahluwalia, J., Devarapu, S.K., Sharma, S.K., Dinda, A.K. and Ghosh, B. (2007) A hexanucleotide repeat upstream of eotaxin gene promoter is associated with asthma, serum total IgE and plasma eotaxin levels. J. Med. Genet., 44, 397-403.
44. Thye, T., Nejentsev, S., Intemann, C.D., Browne, E.N., Chinbuah, M.A., Gyapong, J., Osei, I., Owusu-Dabo, E., Zeitels, L.R., Herb, F. et al. (2009) MCP-1 promoter variant 2362C associated with protection from pulmonary tuberculosis in Ghana, West Africa. Hum. Mol. Genet., 18, 381-388.
45. Modi, W.S., Goedert, J.J., Strathdee, S., Buchbinder, S., Detels, R., Donfield, S., O'Brien, S.J. and Winkler, C. (2003) MCP-1-MCP-3-Eotaxin gene cluster influences HIV-1 transmission. AIDS, 17, 2357-2365.
46. Shen, C., Landers, C.J., Derkowski, C., Elson, C.O. and Targan, S.R. (2008) Enhanced CBir1-specific innate and adaptive immune responses in Crohn's disease. Inflamm. Bowel. Dis., 14, 1641-1651.
47. Duchmann, R., Schmitt, E., Knolle, P., Meyer zum Buschenfelde, K.H. and Neurath, M. (1996) Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur. J. Immunol., 26, 934-938.
48. Pang, H., Koda, Y., Soejima, M., Fujitani, N., Ogaki, T., Saito, A., Kawasaki, T. and Kimura, H. (2001) Polymorphism of the human ABO-Secretor locus (FUT2) in four populations in Asia: indication of distinct Asian subpopulations. Ann. Hum. Genet., 65, 429-437.
49. Yamamoto, K., Miwa, T., Taniguchi, H., Nagano, T., Shimamura, K., Tanaka, T. and Kumagai, H. (1996) Binding specificity of Lactobacillus to glycolipids. Biochem. Biophys. Res. Commun., 228, 148-152.
50. Lee, Y.J., Yu, W.K. and Heo, T.R. (2003) Identification and screening for antimicrobial activity against Clostridium difficile of Bifidobacterium and Lactobacillus species isolated from healthy infant faeces. Int. J. Antimicrob. Agents, 21, 340-346.
51. Moorthy, G., Murali, M.R. and Devaraj, S.N. (2009) Lactobacilli facilitate maintenance of intestinal membrane integrity during Shigella dysenteriae 1 infection in rats. Nutrition, 25, 350-358.
52. Iwamori, M. and Domino, S.E. (2004) Tissue-specific loss of fucosylated glycolipids in mice with targeted deletion of alpha(1,2)fucosyltransferase genes. Biochem. J., 380, 75-81.
53. Lin, B., Saito, M., Sakakibara, Y., Hayashi, Y., Yanagisawa, M. and Iwamori, M. (2001) Characterization of three members of murine alpha1,2-fucosyltransferases: change in the expression of the Se gene in the intestine of mice after administration of microbes. Arch. Biochem. Biophys., 388, 207-215.
54. Meng, D., Newburg, D.S., Young, C., Baker, A., Tonkonogy, S.L., Sartor, R.B., Walker, W.A. and Nanthakumar, N.N. (2007) Bacterial symbionts induce a FUT2-dependent fucosylated niche on colonic epithelium via ERK and JNK signaling. Am. J. Physiol. Gastrointest. Liver Physiol., 293, G780-G787.
55. Collado, M.C., Meriluoto, J. and Salminen, S. (2007) Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus. Lett. Appl. Microbiol., 45, 454-460.
56. Swidsinski, A., Loening-Baucke, V., Vaneechoutte, M. and Doerffel, Y. (2008) Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm. Bowel Dis., 14, 147-161.
57. Hurd, E.A. and Domino, S.E. (2004) Increased susceptibility of secretor factor gene Fut2-null mice to experimental vaginal candidiasis. Infect. Immun., 72, 4279-4281.
58. Park, S.W., Zhen, G., Verhaeghe, C., Nakagami, Y., Nguyenvu, L.T., Barczak, A.J., Killeen, N. and Erle, D.J. (2009) The protein disulfide isomerase AGR2 is essential for production of intestinal mucus. Proc. Natl Acad. Sci. USA, 106, 6950-6955.
59. Johansson, M.E., Phillipson, M., Petersson, J., Velcich, A., Holm, L. and Hansson, G.C. (2008) The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc. Natl Acad. Sci. USA, 105, 15064-15069.
60. van der Sluis, M., Bouma, J., Vincent, A., Velcich, A., Carraway, K.L., Buller, H.A., Einerhand, A.W., van Goudoever, J.B., Van Seuningen, I. and Renes, I.B. (2008) Combined defects in epithelial and immunoregulatory factors exacerbate the pathogenesis of inflammation: mucin 2-interleukin 10-deficient mice. Lab. Invest., 88, 634-642.
61. Heazlewood, C.K., Cook, M.C., Eri, R., Price, G.R., Tauro, S.B., Taupin, D., Thornton, D.J., Png, C.W., Crockford, T.L., Cornall, R.J. et al. (2008) Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis. PLoS Med., 5, e54.
62. An, G., Wei, B., Xia, B., McDaniel, J.M., Ju, T., Cummings, R.D., Braun, J. and Xia, L. (2007) Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans. J. Exp. Med., 204, 1417-1429.
63. Linden, S.K., Sutton, P., Karlsson, N.G., Korolik, V. and McGuckin, M.A. (2008) Mucins in the mucosal barrier to infection. Mucosal. Immunol., 1, 183-197.
64. Frazer, K.A., Ballinger, D.G., Cox, D.R., Hinds, D.A., Stuve, L.L., Gibbs, R.A., Belmont, J.W., Boudreau, A., Hardenbol, P., Leal, S.M. et al. (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature, 449, 851-861.
65. Meijerink, E., Neuenschwander, S., Fries, R., Dinter, A., Bertschinger, H.U., Stranzinger, G. and Vogeli, P. (2000) A DNA polymorphism influencing alpha(1,2)fucosyltransferase activity of the pig FUT1 enzyme determines susceptibility of small intestinal epithelium to Escherichia coli F18 adhesion. Immunogenetics, 52, 129-136.
66. Berglund, E.D., Li, C.Y., Bina, H.A., Lynes, S.G., Michael, M.D., Shanafelt, A.B., Kharitonenkov, A. and Wasserman, D.H. (2009) Fibroblast growth factor 21 (FGF21) controls glycemia via regulation of hepatic glucose flux and insulin sensitivity. Endocrinology, 150, 4084-4093.
67. Inagaki, T., Lin, V.Y., Goetz, R., Mohammadi, M., Mangelsdorf, D.J. and Kliewer, S.A. (2008) Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metab., 8, 77-83.
68. Fried, L.P., Borhani, N.O., Enright, P., Furberg, C.D., Gardin, J.M., Kronmal, R.A., Kuller, L.H., Manolio, T.A., Mittelmark, M.B., Newman, A. et al. (1991) The Cardiovascular Health Study: design and rationale. Ann. Epidemiol., 1, 263-276.
69. Gunderson, K.L., Steemers, F.J., Lee, G., Mendoza, L.G. and Chee, M.S. (2005) A genome-wide scalable SNP genotyping assay using microarray technology. Nat. Genet., 37, 549-554.
70. Gunderson, K.L., Steemers, F.J., Ren, H., Ng, P., Zhou, L., Tsan, C., Chang, W., Bullis, D., Musmacker, J., King, C. et al. (2006) Whole-genome genotyping. Methods Enzymol., 410, 359-376.
71. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A., Bender, D., Maller, J., Sklar, P., de Bakker, P.I., Daly, M.J. et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet., 81, 559-575.
72. Nielsen, D.M., Ehm, M.G. and Weir, B.S. (1998) Detecting marker-disease association by testing for Hardy-Weinberg disequilibrium at a marker locus. Am. J. Hum. Genet., 63, 1531-1540.
73. Wittke-Thompson, J.K., Pluzhnikov, A. and Cox, N.J. (2005) Rational inferences about departures from Hardy-Weinberg equilibrium. Am. J. Hum. Genet., 76, 967-986.
74. Hoh, J., Wille, A. and Ott, J. (2001) Trimming, weighting, and grouping SNPs in human case-control association studies. Genome Res., 11, 2115-2119.
75. Taylor, J. and Tibshirani, R. (2006) A tail strength measure for assessing the overall univariate significance in a dataset. Biostatistics, 7, 167-181
76. Wang, J. and Shete, S. (2008) A test for genetic association that incorporates information about deviation from Hardy-Weinberg proportions in cases. Am. J. Hum. Genet., 83, 53-63.